La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Yestar Healthcare Holdings Crescita futura

Future criteri di controllo 0/6

Al momento non disponiamo di una copertura analitica sufficiente per prevedere la crescita e il fatturato di Yestar Healthcare Holdings.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili	36.2%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	None
Ultimo aggiornamento	n/a

Aggiornamenti recenti sulla crescita futura

Recent updates

Yestar Healthcare Holdings (HKG:2393) Seems To Be Using A Lot Of Debt

Dec 13

These Return Metrics Don't Make Yestar Healthcare Holdings (HKG:2393) Look Too Strong

Oct 18

Is Yestar Healthcare Holdings (HKG:2393) Using Too Much Debt?

Sep 05

One Yestar Healthcare Holdings Company Limited (HKG:2393) Analyst Has Been Cutting Their Forecasts

Sep 05

Returns On Capital At Yestar Healthcare Holdings (HKG:2393) Have Hit The Brakes

Jun 10

These 4 Measures Indicate That Yestar Healthcare Holdings (HKG:2393) Is Using Debt Extensively

Apr 18

What Kind Of Investors Own Most Of Yestar Healthcare Holdings Company Limited (HKG:2393)?

Mar 15

The Returns At Yestar Healthcare Holdings (HKG:2393) Provide Us With Signs Of What's To Come

Feb 07

A Look At Yestar Healthcare Holdings' (HKG:2393) Share Price Returns

Dec 21

Do Institutions Own Yestar Healthcare Holdings Company Limited (HKG:2393) Shares?

Nov 30

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché Yestar Healthcare Holdings non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

SEHK:2393 - Stime future degli analisti e dati finanziari passati (CNY Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
6/30/2024	2,714	1,078	N/A	N/A	N/A
3/31/2024	2,813	534	N/A	N/A	N/A
12/31/2023	2,913	-9	294	388	N/A
6/30/2023	4,691	-823	103	176	N/A
3/31/2023	4,492	-908	-7	42	N/A
12/31/2022	2,805	-460	-118	-92	N/A
9/30/2022	4,434	-633	93	122	N/A
6/30/2022	4,574	-274	303	336	N/A
3/31/2022	4,752	-135	484	525	N/A
12/31/2021	4,931	3	665	715	N/A
9/30/2021	4,879	83	599	671	N/A
6/30/2021	4,827	162	533	628	N/A
3/31/2021	4,467	-214	562	649	N/A
12/31/2020	4,107	-590	591	671	N/A
9/30/2020	4,163	-585	589	656	N/A
6/30/2020	4,218	-580	588	640	N/A
3/31/2020	4,561	-188	489	536	N/A
12/31/2019	4,903	203	390	432	N/A
9/30/2019	4,798	239	345	387	N/A
6/30/2019	4,692	275	300	341	N/A
3/31/2019	4,569	264	225	264	N/A
12/31/2018	4,447	252	150	187	N/A
9/30/2018	4,327	257	146	171	N/A
6/30/2018	4,206	261	143	156	N/A
3/31/2018	4,067	256	N/A	188	N/A
12/31/2017	3,927	250	N/A	221	N/A
9/30/2017	3,637	226	N/A	243	N/A
6/30/2017	3,348	202	N/A	266	N/A
3/31/2017	3,185	201	N/A	281	N/A
12/31/2016	3,022	201	N/A	296	N/A
9/30/2016	2,957	207	N/A	264	N/A
6/30/2016	2,892	213	N/A	232	N/A
3/31/2016	2,673	188	N/A	199	N/A
12/31/2015	2,455	163	N/A	165	N/A
9/30/2015	2,146	141	N/A	101	N/A
6/30/2015	1,837	119	N/A	38	N/A
3/31/2015	1,684	110	N/A	75	N/A
12/31/2014	1,531	101	N/A	113	N/A
9/30/2014	1,442	87	N/A	81	N/A
6/30/2014	1,352	74	N/A	49	N/A
3/31/2014	1,263	69	N/A	42	N/A
12/31/2013	1,173	65	N/A	36	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista 2393 è superiore al tasso di risparmio ( 2.3% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di 2393 cresceranno più velocemente del mercato Hong Kong

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di 2393 cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Dati insufficienti per determinare se si prevede che i ricavi di 2393 cresceranno più rapidamente del mercato Hong Kong.

Ricavi ad alta crescita: Dati insufficienti per determinare se si prevede che i ricavi di 2393 cresceranno più rapidamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di 2393 è previsto essere elevato tra 3 anni

Yestar Healthcare Holdings Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Yestar Healthcare Holdings Company Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022

Yestar Healthcare Holdings Company Limited Provides Earnings Guidance for the Six Months Ended 30 June 2021

Analysts lower EPS estimates to -CN¥0.0047

Recent updates

First half 2024 earnings released: EPS: CN¥0.005 (vs CN¥0.002 in 1H 2023)

New major risk - Share price stability

Yestar Healthcare Holdings Company Limited to Report First Half, 2024 Results on Aug 29, 2024

New minor risk - Financial data availability

Yestar Healthcare Holdings Company Limited, Annual General Meeting, May 31, 2024

Full year 2023 earnings released: CN¥0.005 loss per share (vs CN¥0.43 loss in FY 2022)

Yestar Healthcare Holdings Company Limited to Report Fiscal Year 2023 Results on Mar 27, 2024

Now 30% undervalued after recent price drop

Less than half of directors are independent

Yestar Healthcare Holdings Company Limited to Report First Half, 2023 Results on Aug 25, 2023

Yestar Healthcare Holdings Company Limited Announces Board and Committee Changes

Yestar Healthcare Holdings Company Limited Announces due to Redeem 5% of the Original Principal Amount of the New Senior Notes by 30 December 2022

Yestar Healthcare Holdings (HKG:2393) Seems To Be Using A Lot Of Debt

Now 32% undervalued after recent price drop

Less than half of directors are independent

These Return Metrics Don't Make Yestar Healthcare Holdings (HKG:2393) Look Too Strong

Now 24% undervalued after recent price drop

Is Yestar Healthcare Holdings (HKG:2393) Using Too Much Debt?

One Yestar Healthcare Holdings Company Limited (HKG:2393) Analyst Has Been Cutting Their Forecasts

Yestar Healthcare Holdings Company Limited Announces Redesignation of Hartono James from Executive Director to Non-Executive Director

First half 2022 earnings released: CN¥0.071 loss per share (vs CN¥0.048 profit in 1H 2021)

Yestar Healthcare Holdings Company Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

First half 2021 earnings released: EPS CN¥0.048 (vs CN¥0.27 loss in 1H 2020)

First half 2021 earnings released: EPS CN¥0.048 (vs CN¥0.27 loss in 1H 2020)

Yestar Healthcare Holdings Company Limited Provides Earnings Guidance for the Six Months Ended 30 June 2021

Returns On Capital At Yestar Healthcare Holdings (HKG:2393) Have Hit The Brakes

Independent Non-Executive Director Tirtamarta Karsono has left the company

Full year 2020 earnings released: CN¥0.25 loss per share (vs CN¥0.085 profit in FY 2019)

These 4 Measures Indicate That Yestar Healthcare Holdings (HKG:2393) Is Using Debt Extensively

Full year 2020 earnings released: CN¥0.25 loss per share (vs CN¥0.085 profit in FY 2019)

Yestar Healthcare Holdings Company Limited to Report Fiscal Year 2020 Results on Mar 29, 2021

What Kind Of Investors Own Most Of Yestar Healthcare Holdings Company Limited (HKG:2393)?

The Returns At Yestar Healthcare Holdings (HKG:2393) Provide Us With Signs Of What's To Come

New 90-day low: HK$1.10

New 90-day low: HK$1.18

A Look At Yestar Healthcare Holdings' (HKG:2393) Share Price Returns

New 90-day low: HK$1.23

Do Institutions Own Yestar Healthcare Holdings Company Limited (HKG:2393) Shares?

Analysts lower EPS estimates to -CN¥0.0047

Yestar Healthcare Holdings Company Limited Announces Board Changes

First half earnings released

Earnings released

Yestar Healthcare Holdings Company Limited to Report First Half, 2020 Results on Aug 24, 2020

New 90-day high - HK$1.30

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita